Edit
Journey Medical Corporation
https://journeymedicalcorp.com/Last activity: 26.03.2025
Probably Closed
Investors 1
| Date | Name | Website |
| 28.01.2024 | SWK Holdin... | swkhold.co... |
Mentions in press and media 4
| Date | Title | Description |
| 26.03.2025 | Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights | FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended December 31, 2024 were $56.1 million Met ... |
| 02.10.2024 | ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City | Conference to Feature Leading Healthcare Companies and Institutional Investors for 1x1/Small Group Meetings and Panels NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to a... |
| 04.10.2022 | ROTH Capital Partners to Host Inaugural Healthcare Opportunities Conference on October 6th at the Yale Club in New York City | Event to feature company presentations and one-on-one meetings between institutional investors and senior management from select Healthcare companies in Biotechnology, Pharmaceuticals, Medical Technologies, Oncology and Mental Health Therap... |
| 13.01.2022 | Eye disease biotech raises $46.9M in Series B; Journey Medical Corporation shells out $20M upfront for dermatology franchise | ONL Therapeutics — an Ann Arbor, MI biotech that got its initial backing from Novartis in a 2017 Series A for its lead candidate Fas inhibitor ONL1204 — just got its next cash infusion. The biotech announced this morning tha... |